|
Interpretation and Reporting of Next Generation Sequencing Data in Clinical Oncologic Testing
|
2016-01-12
|
|
|
Dr. Keyur Patel is
an assistant professor and the medical director of the molecular diagnostics
laboratory for hematologic malignancies at the Department of Hematopathology at
the University of Texas M.D. Anderson Cancer Center (UTMDACC). He is
board-certified in anatomic pathology, clinical Pathology, hematopathology and
molecular genetic pathology. In addition, he holds a Ph.D in cell biology and
molecular pathogenesis. His clinical interest includes interpretation of
diagnostic workup for hematologic malignancies and molecular diagnostics. His
research focus is on elucidating pathologic mechanisms in hematologic
malignancies using novel molecular techniques. He has more than 35 peer
reviewed publications to his credit. His current projects involve (i)
understanding the role of miRNA and (ii) use of next generation sequencing in
identifying novel genetic mutations in hematologic malignancies and translating
this knowledge into novel molecular diagnostic approaches for personalized
cancer management. His other professional interests include laboratory
management and molecular test billing.
Date: February 22, 2014 Time: 9:00
am EST (USA)
“Interpretation and Reporting of
Next Generation Sequencing Data in Clinical Oncologic Testing”
Keyur Pravinchandra Patel MD PhD I Assistant
Professor
Medical Director I Molecular Diagnostics Laboratory (Hematologic
Malignancies)
The UT M D Anderson Cancer Center I Pathology and Laboratory Medicine I Hematopathology
1515 Holcombe, Unit 149 Houston, TX 77030
|